Combined bone-building therapy for osteoporosis
Treatments studied
Part of Bones, joints & muscles, Hormones & metabolism clinical trials.
This study tests a combination of two bone-building drugs (romosozumab and teriparatide) in postmenopausal women with osteoporosis who are at high risk for fractures. The goal is to see if the combination strengthens bones faster and better than either drug alone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 45 or older.
- You have gone through menopause (no periods for at least a year).
- You have osteoporosis and a high risk of breaking a bone (e.g., a recent fracture or very low bone density).
- You have not taken strong bone medications in the past (like bisphosphonates or denosumab).
- You do not have other bone diseases, serious kidney/liver/heart/lung problems, or certain lab abnormalities (e.g., low vitamin D or calcium).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at what changes in the body after starting romosozumab (an osteoporosis treatment) in postmenopausal women at higher risk for fractures. Researchers want to understand the treatment’s “mechanism,” which may help improve future osteoporosis care.
This study looks at what medicine works best for women who have finished a 1-year course of a strong bone-building drug (romosozumab or teriparatide) for severe osteoporosis. The goal is to find a good follow-up treatment to keep bones strong and prevent fractures.
This trial is testing a medicine called romosozumab to treat postmenopausal women with severe osteoporosis and a recent fracture. It aims to find the best way to use this drug to strengthen bones and prevent more fractures.
This trial compares two osteoporosis drugs (romosozumab and denosumab) given alone or together to see which works better for improving bone density. It may help if you are a postmenopausal woman with osteoporosis and have not taken strong bone medications recently.
This trial tests whether switching between two medications (Romosozumab and Denosumab) using a cycle or sequence schedule works better for improving bone density in postmenopausal women with severe osteoporosis. It aims to find the most effective treatment plan.
This study tests two injectable medications (romosozumab and abaloparatide) that help strengthen bones in women after menopause. Researchers will also look at blood markers to understand why some women respond better to treatment than others.
Hear when a new Osteoporosis, Postmenopausal trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.